Topps Tiles PLC (TPT)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 36.00 |
|---|---|
| 52-week range | 30.21 – 50.00 |
| Return, 1 month / 3 months | +5.3% / +3.7% |
| Return, 1 year / 3 years | +5.0% / −23.7% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 50.6% |
| Worst drawdown (1 year) | -37.0% |
| Average daily value traded | 8.60M GBX |
| Dividend yield | 8.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Topps Tiles is a British retailer that specialises in wall and floor tiles, along with the adhesives, grout, tools and underlay needed to fit them. It serves homeowners and trade customers through a chain of stores around the United Kingdom and through its online shop, where customers can browse ranges and order samples. The company is based in Leicester and also supplies flooring and related accessories for kitchens, bathrooms and other rooms.
The shares are listed on the London Exchange in UK under the code TPT, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Topps Tiles PLC (TPT) trades on the London Exchange in UK. It last closed at GBX 36.00 on 22 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,147 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.0% and over the last three months it rose 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.2% | ||
| From 52-week high | -28.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.7% | ||
| 6-month return | -6.0% | ||
| 12-month return, skipping the last month | -0.2% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.0% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 8.60M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 89 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.6% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +5.3% |
| 3 months | +3.7% |
| 6 months | −6.0% |
| 1 year | +5.0% |
| 3 years | −23.7% |
| 5 years | −44.7% |
Signals
| 50-day / 200-day average | 34.83 / 36.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | GBP 0.0100 |
| 18 Dec 2025 | GBP 0.0210 |
| 5 Jun 2025 | GBP 0.0080 |
| 19 Dec 2024 | GBP 0.0120 |
| 6 Jun 2024 | GBP 0.0120 |
| 21 Dec 2023 | GBP 0.0240 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.